<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Honkoop, P.</title>
    <link>http://repub.eur.nl/res/aut/460/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Lamivudine Treatment for Chronic Hepatitis B (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/17178/</link>
      <pubDate>1998-04-22T00:00:00Z</pubDate>
      <description>The hepatitis B virus (HBV) is one of the smallest human viruses known and belongs to
the family of Hepadnaviridae; it was the first human hepatitis virus that could be
characterized. Before the discovery of the virus two types of transmission of infectious
hepatitis were distinguished on the basis of epidemiological observations: the classical
hepatitis (type A) was transmitted by the faecal-oral route, while type B was transmitted
parentally.'
In 1963, B8 Blumberg discovered a previously unknown antigen in the blood of an
Australian aboriginal (Australia antigen) and within a few years this was found to be
related to the parentally transmitted type B hepatitis.' In the early seventies the virus was
seen by electron microscopy3 and the genome was found to be a small, circular DNA that
was partially double-stranded (figure I). The nucleotide sequence of the virus contains only
3200 nucleotides (3.2 kb) and revealed 4 overlapping genes for the production of seven
viral proteins.</description>
    </item>
  </channel>
</rss>